GlassScriptPhysician profile
Taylor S Gwin
NPI 1093974099
$6,544.34
in general payments reported to CMS, 2019-2025
37 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,717 · 2020: $1,098 · 2021: $861 · 2022: $712 · 2023: $1,530 · 2024: $316 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,783 · Travel and Lodging: $335 · Education: $39.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,782.65 |
| Travel and Lodging | $334.82 |
| Education | $39.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $1,552.77 | 2019-2022 | |
| W. L. Gore & Associates, INC. | $1,444.88 | 2019-2025 | Gore Tag Thoracic Endoprosthesis, Gore Viabahn Endoprosthesis With Heparin, Gore Propaten Vascular Graft |
| Endologix LLC | $821.58 | 2019-2025 | Endocross Device, Torus Stent Graft System |
| Inari Medical, INC. | $297.14 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $249.28 | 2019-2025 | Collagenase Santyl, Renasys Touch, Grafix Pl |
| Boston Scientific Corporation | $242.38 | 2021-2025 | Eluvia, Enroute Transcarotid Stent, Angiojet Ultra 5000a |
| Janssen Pharmaceuticals, INC | $184.61 | 2020-2023 | Xarelto |
| Shockwave Medical, INC | $156.91 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $122.30 | 2021 | |
| Avinger INC. | $121.23 | 2019-2020 | |
| Tactile Systems Technology INC | $101.03 | 2019-2024 | Flexitouch Plus, Entre Plus |
| Kerecis Limited | $99.34 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Trisalus Life Sciences, INC. | $88.22 | 2023-2025 | Trinav Infusion System |
| Astrazeneca Pharmaceuticals LP | $88.21 | 2020-2024 | Farxiga, Lokelma |
| Fresenius USA Marketing, INC. | $84.95 | 2019-2024 | Velphoro |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $82.71 | 2021-2024 | Endurant Iis, Chameleon |
| Penumbra, INC. | $81.47 | 2023 | Smart Coil |
| Cardiovascular Systems INC. | $77.75 | 2022 | |
| Mimedx Group, INC. | $69.71 | 2024 | |
| Glaxosmithkline, LLC. | $57.16 | 2023 | Jesduvroq |
| Ekos Corporation | $51.63 | 2019 | |
| Humacyte Global, INC. | $45.36 | 2025 | Symvess |
| Sirtex Medical INC | $40.82 | 2022 | |
| Aroa Biosurgery Incorporated | $39.36 | 2023 | |
| Convatec INC. | $35.29 | 2025 | |
| Angiodynamics, INC. | $34.70 | 2022 | |
| Silk Road Medical, INC. | $34.06 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Ethicon US, LLC | $32.08 | 2020 | |
| Sanara Medtech INC. | $29.23 | 2024 | Celleraterx |
| Artivion, INC. | $28.28 | 2019 | |
| Qapel Medical INC | $26.38 | 2023 | |
| Bolton Medical INC | $24.46 | 2019 | |
| Catheter Precision, INC. Fka Ra Medical Systems, INC. | $22.83 | 2019 | |
| Argon Medical Devices, INC. | $20.94 | 2025 | Clot Management |
| Terumo Medical Corporation | $18.78 | 2021 | |
| Abbott Laboratories | $18.39 | 2023 | Diamondback Peripheral |
| Getinge USA Sales, LLC | $18.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Gwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.